Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Cooper

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Health Technology Assessment (Winchester, England)|November 19, 2014
The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluationGeoff Frampton, Petra Harris, Keith Cooper, et al.
Bjpsych Bulletin|January 23, 2020
Supporting people in mental health crisis in 21st-century BritainAndrew Molodynski, Stephen Puntis, Em Mcallister, et al.
Age and Ageing|September 28, 2015
The cost-effectiveness of second-eye cataract surgery in the UKKeith Cooper, Jonathan Shepherd, Geoff Frampton, et al.
Bjpsych Bulletin|December 16, 2020
Supporting people in mental health crisis in 21st-century Britain - ERRATUMAndrew Molodynski, Stephen Puntis, Em Mcallister, et al.
Integrated Environmental Assessment and Management|June 12, 2014
Improving management support tools for reintroducing bivalve species (eastern oyster [Crassostrea virginica Gmelin]) in urban estuariesBeth Ravit, Keith Cooper, Brian Buckley, et al.
Health Technology Assessment (Winchester, England)|May 3, 2016
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluationJonathan Shepherd, Keith Cooper, Petra Harris, et al.
Journal of Viral Hepatitis|September 15, 2019
The testing of people with any risk factor for hepatitis C in community pharmacies is cost-effectiveRyan Buchanan, Keith Cooper, Leonie Grellier, et al.
Health Technology Assessment (Winchester, England)|October 29, 2014
The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluationDebbie Hartwell, Keith Cooper, Geoff K Frampton, et al.
Pharmacoeconomics|October 18, 2018
Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalJoanna Picot, Neelam Kalita, Wendy Gaisford, et al.
Pharmacoeconomics|March 28, 2018
Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology AppraisalKeith Cooper, Geoff Frampton, Petra Harris, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Health Technology Assessment (Winchester, England)|November 19, 2014
The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluationGeoff Frampton, Petra Harris, Keith Cooper, et al.
Bjpsych Bulletin|January 23, 2020
Supporting people in mental health crisis in 21st-century BritainAndrew Molodynski, Stephen Puntis, Em Mcallister, et al.
Age and Ageing|September 28, 2015
The cost-effectiveness of second-eye cataract surgery in the UKKeith Cooper, Jonathan Shepherd, Geoff Frampton, et al.
Bjpsych Bulletin|December 16, 2020
Supporting people in mental health crisis in 21st-century Britain - ERRATUMAndrew Molodynski, Stephen Puntis, Em Mcallister, et al.
Integrated Environmental Assessment and Management|June 12, 2014
Improving management support tools for reintroducing bivalve species (eastern oyster [Crassostrea virginica Gmelin]) in urban estuariesBeth Ravit, Keith Cooper, Brian Buckley, et al.
Health Technology Assessment (Winchester, England)|May 3, 2016
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluationJonathan Shepherd, Keith Cooper, Petra Harris, et al.
Journal of Viral Hepatitis|September 15, 2019
The testing of people with any risk factor for hepatitis C in community pharmacies is cost-effectiveRyan Buchanan, Keith Cooper, Leonie Grellier, et al.
Health Technology Assessment (Winchester, England)|October 29, 2014
The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluationDebbie Hartwell, Keith Cooper, Geoff K Frampton, et al.
Pharmacoeconomics|October 18, 2018
Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalJoanna Picot, Neelam Kalita, Wendy Gaisford, et al.
Pharmacoeconomics|March 28, 2018
Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology AppraisalKeith Cooper, Geoff Frampton, Petra Harris, et al.
Pageof 4